Suture Anchor Devices Market

By Product Type;

Absorbable and Non-Absorbable

By Tying Type;

Knotted Suture Anchors and Knotless

By Material Type;

Metallic Suture Anchor, Bio-Absorbable Suture Anchor, PEEK Suture Anchor, Bio-Composite Suture Anchor, and All Suture Anchor

By End User;

Hospitals, Emergency Medical Services, Clinics, and Ambulatory Surgical Centres

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn826112464 Published Date: August, 2025

Suture Anchor Devices Market Overview

Suture Anchor Devices Market (USD Million)

Suture Anchor Devices Market was valued at USD 666.31 million in the year 2024. The size of this market is expected to increase to USD 918.97 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.7%.


Suture Anchor Devices Market

*Market size in USD million

CAGR 4.7 %


Study Period2025 - 2031
Base Year2024
CAGR (%)4.7 %
Market Size (2024)USD 666.31 Million
Market Size (2031)USD 918.97 Million
Market ConcentrationHigh
Report Pages326
666.31
2024
918.97
2031

Major Players

  • Smith & Nephew plc
  • Zimmer Biomet Holdings Inc
  • ConMed Corporation
  • Arthrex Inc
  • Johnson and Johnson (DePuy Synthes, Inc.)
  • Medtronic plc
  • Stryker Corporation
  • Parcus Medical LLC
  • Anika Therapeutics
  • Stryker
  • OSSIO

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Suture Anchor Devices Market

Fragmented - Highly competitive market without dominant players


The Suture Anchor Devices Market is experiencing robust growth as orthopedic surgeons and sports medicine specialists increasingly adopt high-strength implant anchors for tendon and ligament repair. Nearly 65% of repair procedures now use bioabsorbable or all‑suture anchors to ensure secure fixation. This uptick is driving innovation and market expansion, supported by collaboration between clinical experts and medical device engineers.

Anchor Design Enhancing Surgical Precision
Around 62% of manufacturers are rolling out anchors with advancements such as dual‑load suturing capability, polymer–metal hybrid structures, biodegradable materials, and color‑coded sizing. These technological advancements enhance fixation strength and surgical efficiency. Joint efforts between surgeons and R&D teams are accelerating improved anchor design.

Clinical Programs Boosting Adoption Rates
Collaborative clinical studies and adoption programs involving orthopedic hospitals, device innovators, and surgical training centers have resulted in a 59% increase in utilization of advanced anchor systems. These cross-functional collaborations ensure anatomically precise placement techniques, surgeon certification, and outcome monitoring—driving growth through procedural excellence.

Next‑Gen Anchor Technology Leading Surgical Evolution
Looking forward, over 70% of next-generation anchor devices are expected to incorporate smart suture tracking, integrated tension sensors, and bioactive surface coatings promoting tissue integration. These innovations mark a shift toward adaptive surgical fixation solutions, enabling real‑time feedback, enhanced healing, and reduced revision rates.

In this report, the Suture Anchor Devices Market has been segmented by Product Type, Tying Type, Material Type, End User, and Geography.

Suture Anchor Devices Market, Segmentation by Product Type

The Suture Anchor Devices Market has been segmented by Product Type into Absorbable and Non-Absorbable.

Absorbable
Absorbable suture anchors accounted for nearly 46 – 47 % of the global suture anchor devices market in 2024. They are increasingly popular due to their ability to naturally degrade, avoiding surgical removal and minimizing long‑term implant‑related complications. This segment is the fastest‑growing, with projected CAGRs of about 8 % through 2030. Supported by innovations in bio‑polymers and the rise of arthroscopic soft‑tissue procedures, absorbable anchors are gaining traction in sports medicine and minimally invasive orthopedic surgeries.

Non‑Absorbable
Non‑absorbable suture anchors continued to lead the market with over 53 % share in 2024, driven by their exceptional mechanical strength and durable fixation in demanding orthopedic applications. While growth is steadier at around 3.5 – 4.5 % annually, these anchors remain essential for procedures requiring long‑term stability—such as tendon and ligament repairs. Advanced substances like PEEK and titanium offer compatibility with imaging and improve clinical reliability, reinforcing their dominance in surgical settings.

Suture Anchor Devices Market, Segmentation by Tying Type

The Suture Anchor Devices Market has been segmented by Tying Type into Knotted Suture Anchors and Knotless.

Knotless Suture Anchors
Knotless suture anchors captured roughly 44–56 % of the global suture anchor devices market in 2024. These anchors simplify surgical workflows by eliminating knot tying, delivering uniform tension, reducing operation time, and enhancing tissue protection. Clinical research has also shown that knotless systems result in lower soft‑tissue irritation and streamline postoperative recovery—making them the preferred choice for arthroscopic and minimally invasive procedures.

Knotted Suture Anchors
Knotted suture anchors accounted for approximately 40–56 % share in 2024, offering surgeons the ability to fine‑tune tension intraoperatively—especially valuable in demanding tendon and ligament repairs. While typically more affordable, these systems require longer surgical time and can create knot bulk, which may lead to postoperative discomfort. As clinical teams prioritize efficiency, knotted anchors remain in use where precision and cost‑control outweigh speed advantages.

Suture Anchor Devices Market, Segmentation by Material Type

The Suture Anchor Devices Market has been segmented by Material Type into Metallic Suture Anchor, Bio-Absorbable Suture Anchor, PEEK Suture Anchor, Bio-Composite Suture Anchor and All Suture Anchor.

Metallic Suture Anchor
Metallic suture anchors continue to serve niche surgical roles, particularly in high-load-bearing revisions and trauma settings, thanks to their unmatched mechanical strength and minimal anchor displacement. Though less favored in MRI-sensitive scenarios, they maintain clinical relevance where permanent fixation is essential.

Bio‑Absorbable Suture Anchor
Bio-absorbable suture anchors offer the advantage of gradual resorption, eliminating long-term implant retention and minimizing imaging artifacts. As of 2024, they likely accounted for around one-quarter to one-third of the material-based market, with projected CAGR of ≈8.15 % through 2030 driven by regulatory gains and improved biomaterial performance.

PEEK Suture Anchor
PEEK anchors dominated the material segment in 2024 with approximately 35.5 % market share. They deliver bone-like strength, radiolucency compatible with CT/MRI, and consistent durability—especially in shoulder and hip arthroscopies—making them a surgeon-favorite for mid to long-term fixation needs.

Bio‑Composite Suture Anchor
Bio-composite anchors are estimated to have captured about 50.4 % of revenue by 2025, indicating dominance in the material category. They combine bioactive ceramics with polymers to enable bone integration and minimize inflammatory response, driving rapid clinical adoption and revenue growth.

All Suture Anchor
All-suture anchors, composed entirely of soft materials, occupy a growing share of the “others” category. Appreciated for requiring minimal drill size, offering a low implant profile, and delivering high stiffness, these anchors are gaining traction where bone preservation and minimal tissue disruption are priorities.

Suture Anchor Devices Market, Segmentation by End User

Hospitals
Hospitals commanded around 67.7 % of the global suture anchor devices market in 2024. Their dominance stems from high surgical volumes—including procedures like tendon and ligament repairs—and access to cutting-edge anchor technology. With built-in surgical infrastructure and strong demand for advanced fixation systems, hospitals continue as the primary anchor purchasers.

Ambulatory Surgical Centres
ASCs comprised approximately 24.8 % of global market revenue in 2024 and are projected to grow fastest, with a ~10.2 % CAGR through 2030. Favored for minimally invasive outpatient orthopedic surgeries, ASCs offer efficient care delivery and faster recovery timelines, fueling their rapid adoption.

Clinics
Orthopedic clinics, often merged with hospital data, play a pivotal role in the ~67.7 % share. Focused on musculoskeletal care, they deliver customized treatments with emphasis on value, patient convenience, and procedure‑specific protocols.

Emergency Medical Services (EMS)/Other End Users
EMS support services, minor procedure units, and mobile surgical setups represent the remaining ~7–8 % of market usage. While smaller in scale, they are vital in delivering urgent or trauma-related soft‑tissue repairs, particularly in remote or emergency settings.

Suture Anchor Devices Market, Segmentation by Geography

In this report, the Suture Anchor Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Regions and Countries Analyzed in this Report

Legend
North America
Rest of North America
Europe
Rest of Europe
Asia Pacific
Rest of Asia Pacific
Middle East and Africa
Rest of Middle East and Africa
Latin America
Rest of Latin America
Rest of the World

Suture Anchor Devices Market Share (%), by Geographical Region

North America
North America led the suture anchor devices industry in 2024 with roughly 41–42.5 % market share. Its dominance is driven by high rates of orthopedic surgeries, especially sports injury treatments, world-class healthcare infrastructure, and early uptake of innovative anchor solutions.

Europe
Europe ranked second globally in 2024 with nearly 25 % share, supported by demographic trends such as an aging population and increasing musculoskeletal disorders. Strong demand in sports medicine and regulatory support further sustain anchor utilization.

Asia Pacific
Asia Pacific held about 24.9 % of market revenue in 2024 and is expected to deliver the fastest regional growth, with a projected ~4.6 % CAGR through 2030. Healthcare modernization, increasing surgery volumes from sports injury and degenerative conditions, and expansion in China and India drive this growth.

Middle East and Africa
MEA made up under 5 % of the global market in 2024, representing a smaller regional share but gradually growing. Investments in healthcare infrastructure, especially in GCC countries, are expanding access to orthopedic interventions.

Latin America
Latin America accounted for approximately 5 % of global market revenue in 2024. Although penetration remains modest, adoption is increasing, particularly in Brazil and Mexico, where minimally invasive orthopedic techniques are becoming more prevalent.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product Type
    2. Market Snapshot, By Tying Type
    3. Market Snapshot, By Material Type
    4. Market Snapshot, By End User
    5. Market Snapshot, By Region
  4. Suture Anchor Devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Ligament reconstruction

        2. Biomechanical properties

        3. Healthcare infrastructure

        4. Healthcare expenditure

      2. Restraints
        1. Product recalls or quality issues

        2. Healthcare budget constraints

        3. Reimbursement issues

        4. Supply chain disruptions

      3. Opportunities
        1. Aging Population

        2. Next-Generation Designs

        3. Biomechanical Improvements

        4. Enhanced Surgical Outcomes

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Suture Anchor Devices Market, By Product Type, 2021 - 2031 (USD Million)
      1. Absorbable
      2. Non-Absorbable
    2. Suture Anchor Devices Market, By Tying Type, 2021 - 2031 (USD Million)
      1. Knotted Suture Anchors
      2. Knotless
    3. Suture Anchor Devices Market, By Material Type, 2021 - 2031 (USD Million)
      1. Metallic Suture Anchor
      2. Bio-Absorbable Suture Anchor
      3. PEEK Suture Anchor
      4. Bio-Composite Suture Anchor
      5. All Suture Anchor
    4. Suture Anchor Devices Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Emergency Medical Services
      3. Clinics
      4. Ambulatory Surgical Centres
    5. Suture Anchor Devices Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea ASEAN (Association of South East Asian Countries)
        6. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Smith & Nephew plc
      2. Zimmer Biomet Holdings Inc
      3. ConMed Corporation
      4. Arthrex Inc
      5. Johnson and Johnson (DePuy Synthes Inc)
      6. Medtronic plc
      7. Stryker Corporation
      8. Parcus Medical LLC
      9. Anika Therapeutics
      10. Stryker
      11. OSSIO
  7. Analyst Views
  8. Future Outlook of the Market